HLRCC is associated with variants in the fumarate hydratase (FH) gene, encoding the FH protein, where, following a second somatic alteration in the gene, the accumulation of fumarate results in a pro-oncogenic milieu, potentially leading to an aggressive pRCC [34,35]. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.